BBS2 and amyotrophic lateral sclerosis: Furthermore, we investigated how modulating APP processing and expression, by monoclonal antibody (MAb) that blocks the BACE cleavage site on its APP substrate (BBS), affects the progression of pathology in SOD1G93A ALS mouse and cellular models.